1,2-dipalmitoylphosphatidylcholine has been researched along with cyclin d1 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagde, A; Behl, G; Boakye, CHA; Chowdhury, N; Doddapaneni, R; Patel, K; Safe, S; Singh, M | 1 |
1 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and cyclin d1
| Article | Year |
|---|---|
Ultra-flexible nanocarriers for enhanced topical delivery of a highly lipophilic antioxidative molecule for skin cancer chemoprevention.
Topics: 1,2-Dipalmitoylphosphatidylcholine; 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Carcinogenesis; Chemoprevention; Cyclin D1; Deoxyguanosine; DNA Damage; Drug Carriers; Drug Compounding; Fatty Acids, Monounsaturated; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Indoles; Interleukin-10; Mice; Nanoparticles; Permeability; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-myc; Quaternary Ammonium Compounds; Skin; Skin Neoplasms; Tumor Suppressor Protein p53; Ultraviolet Rays | 2016 |